Effects of enzyme replacement therapy on immune function in ADA deficiency patient

Clin Immunol. 2015 Dec;161(2):391-3. doi: 10.1016/j.clim.2015.06.011. Epub 2015 Jun 27.
No abstract available

Keywords: Adenosine deaminase deficiency; Enzyme replacement therapy; Immune reconstitution; PEG-ADA; Severe combined immunodeficiency; Stem cell gene therapy.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / blood
  • Adenosine Deaminase / deficiency*
  • Adenosine Deaminase / immunology
  • Adenosine Deaminase / metabolism
  • Adenosine Deaminase / therapeutic use
  • Adolescent
  • Agammaglobulinemia / drug therapy*
  • Agammaglobulinemia / enzymology
  • Agammaglobulinemia / immunology
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism
  • Enzyme Replacement Therapy / methods*
  • Female
  • Flow Cytometry
  • Humans
  • Lymphocyte Count
  • Severe Combined Immunodeficiency / drug therapy*
  • Severe Combined Immunodeficiency / enzymology
  • Severe Combined Immunodeficiency / immunology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Treatment Outcome

Substances

  • Adenosine Deaminase
  • pegademase bovine

Supplementary concepts

  • Severe combined immunodeficiency due to adenosine deaminase deficiency